Surmodics to Participate in Upcoming Investor Conferences in March and April
27 Febbraio 2024 - 2:00PM
Business Wire
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical
device and in vitro diagnostic technologies to the healthcare
industry, today announced that management will participate in the
following upcoming investor conferences:
The 34th Annual Oppenheimer Healthcare Conference, which
is being held virtually from March 12-13, 2024.
- Management will present on Wednesday, March 13, at 2:00 p.m.
Eastern Time.
The 23rd Annual Needham Healthcare Conference, which is
being held virtually from April 8-11, 2024.
- Management will participate in a fireside chat on Tuesday,
April 9, at 3:00 p.m. Eastern Time.
To access live webcasts of the presentations, go to “Events
& Presentations” under the “Investors” section of the Company’s
website at https://surmodics.gcs-web.com/events-and-presentations,
and click on the webcast icon under “Upcoming Events.” Replays of
the webcasts will be archived on the website for the following 90
days.
About Surmodics, Inc.
Surmodics is a leading provider of performance coating
technologies for intravascular medical devices and chemical and
biological components for in vitro diagnostic immunoassay tests and
microarrays. Surmodics also develops and commercializes highly
differentiated vascular intervention medical devices that are
designed to address unmet clinical needs and engineered to the most
demanding requirements. This key growth strategy leverages the
combination of the Company’s expertise in proprietary surface
modification and drug-delivery coating technologies, along with its
device design, development, and manufacturing capabilities. The
Company’s mission is to improve the detection and treatment of
disease. Surmodics is headquartered in Eden Prairie, Minnesota. For
more information, visit www.surmodics.com. The content of
Surmodics’ website is not part of this press release or part of any
filings that the company makes with the Securities and Exchange
Commission.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240227712577/en/
Surmodics Investor Inquiries: Jack Powell, Investor Relations
ir@surmodics.com
Grafico Azioni SurModics (NASDAQ:SRDX)
Storico
Da Gen 2025 a Feb 2025
Grafico Azioni SurModics (NASDAQ:SRDX)
Storico
Da Feb 2024 a Feb 2025